These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32249529)

  • 1. Classifying Remission in Rheumatoid Arthritis Treat-to-Target Studies: Comment on the Article by Norvang et al.
    Xie W; Zhang Z
    Arthritis Rheumatol; 2020 Aug; 72(8):1406-1407. PubMed ID: 32249529
    [No Abstract]   [Full Text] [Related]  

  • 2. Definition of rheumatoid arthritis remission in clinical practice: comment on the article by Felson et al.
    Block SR
    Arthritis Rheum; 2011 Nov; 63(11):3642; author's reply 3644. PubMed ID: 21792824
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical contrasts with the American College of Rheumatology/European League Against Rheumatism provisional definitions of remission in rheumatoid arthritis for clinical trials: Comment on the article by Felson et al.
    Rotar Z; Praprotnik S; Tomšič M
    Arthritis Rheum; 2011 Nov; 63(11):3642-3; author's reply 3644. PubMed ID: 21792830
    [No Abstract]   [Full Text] [Related]  

  • 4. A suggestion and the larger perspective on the American College of Rheumatology/European League Against Rheumatism remission definitions: comment on the article by Felson et al.
    Johnson K
    Arthritis Rheum; 2011 Nov; 63(11):3643-4; author's reply 3644. PubMed ID: 21792825
    [No Abstract]   [Full Text] [Related]  

  • 5. Does treatment with glucocorticoids or with disease-modifying antirheumatic drugs reduce the rate of radiographic progression in rheumatoid arthritis? Comment on the article by Abu-Shakra et al.
    Kirwan JR
    Arthritis Rheum; 1999 May; 42(5):1066-7. PubMed ID: 10323469
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral glucocorticoids should be included in any recommendation for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis: comment on the article by Singh et al.
    Conn DL
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1622-3; author reply 1623-4. PubMed ID: 23024030
    [No Abstract]   [Full Text] [Related]  

  • 7. Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Comment on the article by Saag et al.
    van Tuyl LH; Lems WF; Voskuyl AE; Dijkmans BA; Boers M; Kerstens PJ
    Arthritis Rheum; 2009 Jan; 61(1):141-2; author reply 141-2. PubMed ID: 19116962
    [No Abstract]   [Full Text] [Related]  

  • 8. Trials in rheumatoid arthritis: choosing the right outcome measures--comment on the article by Felson et al.
    Porter D
    Ann Rheum Dis; 2008 Sep; 67(9):1356. PubMed ID: 18697785
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiographic progression in early rheumatoid arthritis: comment on the article by Goronzy et al.
    Sanmarti R; Gómez-Centeno A; Gratacós J; Cañete JD
    Arthritis Rheum; 2004 Sep; 50(9):3052-3; author reply 3053-4. PubMed ID: 15457481
    [No Abstract]   [Full Text] [Related]  

  • 10. Underestimation of the reliability of codes for rheumatoid arthritis within administrative data: comment on the article by Ng et al.
    Schmajuk G; Yazdany J
    Arthritis Care Res (Hoboken); 2013 May; 65(5):835-6. PubMed ID: 23212977
    [No Abstract]   [Full Text] [Related]  

  • 11. Insufficient reporting on race and ethnicity in randomized trials for patients with rheumatoid arthritis: comment on the article by Simsek et al.
    Potter J; Spruill T; Greenberg JD
    Arthritis Care Res (Hoboken); 2013 Apr; 65(4):666. PubMed ID: 23212944
    [No Abstract]   [Full Text] [Related]  

  • 12. Rheumatoid arthritis subgroup with type I interferon signature: comment on the article by Thurlings et al.
    Park JK
    Arthritis Rheum; 2011 Dec; 63(12):4033; author reply 4033-4. PubMed ID: 21882169
    [No Abstract]   [Full Text] [Related]  

  • 13. Level of the indication of biologic agents in the 2012 American College of Rheumatology recommendations for the treatment of rheumatoid arthritis: comment on the article by Singh et al.
    Graudal N; Jürgens G
    Arthritis Care Res (Hoboken); 2013 May; 65(5):832. PubMed ID: 23097263
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiographic benefit without clinical improvement in infliximab-treated patients with rheumatoid arthritis: comment on the article by Smolen et al.
    Pincus T; Yazici Y; Yazici H; Kavanaugh AF; Kremer JM; Wolfe F
    Arthritis Rheum; 2005 Dec; 52(12):4044-5; author reply 4045-7. PubMed ID: 16320353
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of folic acid supplementation on the efficacy of methotrexate treatment in rheumatoid arthritis: comment on the article by Khanna et al.
    Morgan SL; Baggott JE; Alarcón GS
    Arthritis Rheum; 2006 May; 54(5):1708-9; author reply 1709-10. PubMed ID: 16646062
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of golimumab combined with methotrexate on radiographic progression in rheumatoid arthritis: comment on the article by Emery et al.
    Graudal N; Jürgens G
    Arthritis Rheum; 2012 Apr; 64(4):1297-8; author reply 1298-9. PubMed ID: 22231914
    [No Abstract]   [Full Text] [Related]  

  • 17. On publication policy, combination therapy, and the European League Against Rheumatism recommendations for the management of rheumatoid arthritis: comment on the article by Graudal et al.
    Landewé R; Gorter S; Gaujoux-Viala C; Gossec L; Smolen JS
    Arthritis Rheum; 2011 Oct; 63(10):3182-4; discussion 3184-6. PubMed ID: 21702017
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel approaches to discovery of biomarkers in rheumatoid arthritis: comment on the article by Oswald et al.
    Hudson M; Baron M; Colmegna I; Bernatsky S; Klein Oros K; Pastinen T; Greenwood C
    Arthritis Rheumatol; 2015 May; 67(8):2276-7. PubMed ID: 25988805
    [No Abstract]   [Full Text] [Related]  

  • 19. Reexamining remission definitions in rheumatoid arthritis: considering the 28-joint Disease Activity Score, C-reactive protein level, and patient global assessment: comment on the article by Felson et al.
    Ferreira RJO; Welsing PMJ; Jacobs JWG; Gossec L; Ndosi M; Machado PM; van der Heijde D; da Silva JAP
    Arthritis Care Res (Hoboken); 2022 Mar; 74(3):501-502. PubMed ID: 34931481
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of triple therapy versus etanercept plus methotrexate in rheumatoid arthritis: comment on the article by Moreland et al.
    Graudal N; Jürgens G
    Arthritis Rheum; 2013 Feb; 65(2):539. PubMed ID: 23125025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.